Apollomics APLM
NASDAQ APLM
$24.33 +0.76 (+3.21%)
As of: Aug 21, 2026 · 3:19 PM EDT

Apollomics (APLM) Cash & Current Investments (2020 - 2025)

Apollomics (APLM) posted quarterly Cash & Current Investments of $3.3 million for Q4 2025, down 92.83% quarter-over-quarter from $45.7 million in Q2 2023.

Apollomics (APLM) Cash & Current Investments (2020 - 2025) Analysis & Trends

Apollomics (APLM) has reported Cash & Current Investments for 5 consecutive years, with $3.3 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Cash & Current Investments changed N/A year-over-year to $3.3 million; the TTM figure through Dec 2025 stood at $3.3 million (changed N/A YoY), while the FY2025 annual figure was $3.3 million, changed N/A from the prior year.
  • Cash & Current Investments retreated to $3.3 million in Q4 2025 per APLM's latest filing, from $45.7 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $51.7 million in Q4 2022 and bottomed at $3.3 million in Q4 2025.
  • Historically, Cash & Current Investments has averaged $36.3 million across 4 years, with a median of $45.7 million in 2023.
  • Annual changes were most pronounced in 2021 — Cash & Current Investments sank 76.86% — and 2022, when it soared 71.16%.
  • Apollomics' Cash & Current Investments stood at $30.2 million in 2021, then jumped by 71.16% to $51.7 million in 2022, then decreased by 11.68% to $45.7 million in 2023, then sank by 92.83% to $3.3 million in 2025.
  • Business Quant data shows APLM's Cash & Current Investments at $3.3 million in Q4 2025, $45.7 million in Q2 2023, and $51.7 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.14 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 3.31 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 18.39 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.16 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 836.99 Mn
10 Apollomics 35.18 Mn 31.90 Mn - 3.28 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.28 Mn
Jun 30, 2023 45.70 Mn
Dec 31, 2022 51.74 Mn
Jun 30, 2022 50.70 Mn
Dec 31, 2021 30.23 Mn
Dec 31, 2020 130.65 Mn